Mangoceuticals, Inc.
MGRX
$2.04
$0.000.00%
NASDAQ
03/31/2025 | 12/31/2024 | ||||
---|---|---|---|---|---|
Revenue | 3.90% | -21.14% | |||
Total Other Revenue | -- | -- | |||
Total Revenue | 3.90% | -21.14% | |||
Cost of Revenue | 88.05% | -50.49% | |||
Gross Profit | -22.47% | -3.14% | |||
SG&A Expenses | 100.71% | 9.86% | |||
Depreciation & Amortization | -- | -- | |||
Other Operating Expenses | -- | -- | |||
Total Operating Expenses | 42.38% | 52.08% | |||
Operating Income | -44.09% | -58.57% | |||
Income Before Tax | -148.36% | 2.56% | |||
Income Tax Expenses | -- | -- | |||
Earnings from Continuing Operations | -148.36% | 2.56% | |||
Earnings from Discontinued Operations | -- | -- | |||
Extraordinary Item & Accounting Change | -- | -- | |||
Minority Interest in Earnings | -50.00% | -60.00% | |||
Net Income | -148.38% | 2.54% | |||
EBIT | -44.09% | -58.57% | |||
EBITDA | -81.69% | -10.57% | |||
EPS Basic | 2.11% | -8.42% | |||
Normalized Basic EPS | -41.73% | 25.11% | |||
EPS Diluted | 2.11% | -8.42% | |||
Normalized Diluted EPS | -41.73% | 25.11% | |||
Average Basic Shares Outstanding | 75.26% | 30.14% | |||
Average Diluted Shares Outstanding | 75.26% | 30.14% | |||
Dividend Per Share | -- | -- | |||
Payout Ratio | -- | -- |